Evidence map›Paper›PMID 22307622›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Dickkopf-3, an immune modulator in peripheral CD8 T-cell tolerance.

Maria Papatriantafyllou, Gerhard Moldenhauer, Julia Ludwig, Anna Tafuri, Natalio Garbi, Gorana Hollmann, Günter Küblbeck, Alexandra Klevenz, Sabine Schmitt, Georg Pougialis and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Polyfunctional CD8Molecular oncology · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Maria PapatriantafyllouDepartment of Molecular Immunology, German Cancer Research Center and Institute of Molecular Biology, Mainz 55128, Germany.
Gerhard Moldenhauer
Julia Ludwig
Anna Tafuri
Natalio Garbi
Gorana Hollmann
Günter Küblbeck
Alexandra Klevenz
Sabine Schmitt
Georg Pougialis
Christof Niehrs
Hermann-Josef Gröne
Gunter J Hämmerling
Bernd Arnold
Thilo Oelert
Center of Molecular Immunology (Cuba) · CUNational Academy of Sciences of Armenia · AMHeidelberg University · DEInstitute of Molecular Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In healthy individuals, T cells react against incoming pathogens, but remain tolerant to self-antigens, thereby preventing autoimmune reactions. CD4 regulatory T cells are major contributors in induction and maintenance of peripheral tolerance, but a regulatory role has been also reported for several subsets of CD8 T cells. To determine the molecular basis of peripheral CD8 T-cell tolerance, we exploited a double transgenic mouse model in which CD8 T cells are neonatally tolerized following interaction with a parenchymal self-antigen. These tolerant CD8 T cells have regulatory capacity and can suppress T cells in an antigen-specific manner during adulthood. Dickkopf-3 (DKK3) was found to be expressed in the tolerant CD8 T cells and to be essential for the observed CD8 T-cell tolerance. In vitro, genetic deletion of DKK3 or blocking with antibodies restored CD8 T-cell proliferation and IL-2 production in response to the tolerizing self-antigen. Moreover, exogenous DKK3 reduced CD8 T-cell reactivity. In vivo, abrogation of DKK3 function reversed tolerance, leading to eradication of tumors expressing the target antigen and to rejection of autologous skin grafts. Thus, our findings define DKK3 as a immune modulator with a crucial role for CD8 T-cell tolerance.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBlotting, WesternCD8-Positive T-LymphocytesCell ProliferationCytotoxicity, ImmunologicFlow CytometryImmune ToleranceIntercellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, TransgenicReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionAdaptor Proteins, Signal TransducingDkk3 protein, mouseIntercellular Signaling Peptides and Proteins

Identifiers

PMID22307622
PMCPMC3277179
OpenAlexW2141301605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.